Achiko AG (Achiko AG) Retained Earnings : $-33.79 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Achiko AG's retained earnings for the quarter that ended in Jun. 2022 was $-33.79 Mil.

Achiko AG's quarterly retained earnings declined from Jun. 2021 ($-30.11 Mil) to Dec. 2021 ($-34.57 Mil) but then increased from Dec. 2021 ($-34.57 Mil) to Jun. 2022 ($-33.79 Mil).

Achiko AG's annual retained earnings declined from Dec. 2019 ($-11.17 Mil) to Dec. 2020 ($-25.15 Mil) and declined from Dec. 2020 ($-25.15 Mil) to Dec. 2021 ($-34.57 Mil).

Achiko AG Retained Earnings Historical Data

The historical data trend for Achiko AG's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Retained Earnings Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Retained Earnings

-3.88

-11.17

-25.15

-34.57

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Retained Earnings	Get a 7-Day Free Trial			-15.82	-25.15	-30.11	-34.57	-33.79

Achiko AG Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Achiko AG (OTCPK:ACHKF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.